Current and historical daily PE Ratio for ORMP (
Oramed Pharmaceuticals Inc
) from 2007 to May 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Oramed Pharmaceuticals stock (ORMP) PE ratio as of May 20 2024 is 8.85.
More Details
Oramed Pharmaceuticals Inc (ORMP) PE Ratio (TTM) Chart
Oramed Pharmaceuticals Inc (ORMP) PE Ratio (TTM) Historical Data
View and export this data going back to 2007. Start your Free Trial
Total 1255
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Oramed Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-20 | 8.8 | 2024-03-15 | 20.9 |
| 2024-05-17 | 8.8 | 2024-03-14 | 19.1 |
| 2024-05-16 | 9.0 | 2024-03-13 | 19.8 |
| 2024-05-15 | 9.2 | 2024-03-12 | 20.4 |
| 2024-05-14 | 9.5 | 2024-03-11 | 21.0 |
| 2024-05-13 | 9.3 | 2024-03-08 | 21.3 |
| 2024-05-10 | 9.2 | 2024-03-07 | 20.4 |
| 2024-05-09 | 9.2 | 2024-03-06 | 20.5 |
| 2024-05-08 | 9.3 | 2024-03-05 | 23.3 |
| 2024-05-07 | 9.2 | 2024-03-04 | 23.2 |
| 2024-05-06 | 9.6 | 2024-03-01 | 24.4 |
| 2024-05-03 | 9.0 | 2024-02-29 | 23.5 |
| 2024-05-02 | 9.0 | 2024-02-28 | 24.4 |
| 2024-05-01 | 9.0 | 2024-02-27 | 25.6 |
| 2024-04-30 | 8.9 | 2024-02-26 | 25.4 |
| 2024-04-29 | 9.4 | 2024-02-23 | 24.7 |
| 2024-04-26 | 9.5 | 2024-02-22 | 23.6 |
| 2024-04-25 | 8.8 | 2024-02-21 | 22.9 |
| 2024-04-24 | 9.1 | 2024-02-20 | 22.5 |
| 2024-04-23 | 9.0 | 2024-02-16 | 22.4 |
| 2024-04-22 | 9.0 | 2024-02-15 | 22.4 |
| 2024-04-19 | 8.7 | 2024-02-14 | 22.4 |
| 2024-04-18 | 8.5 | 2024-02-13 | 21.6 |
| 2024-04-17 | 9.0 | 2024-02-12 | 22.6 |
| 2024-04-16 | 9.2 | 2024-02-09 | 20.4 |
| 2024-04-15 | 9.3 | 2024-02-08 | 19.2 |
| 2024-04-12 | 9.7 | 2024-02-07 | 20.3 |
| 2024-04-11 | 9.9 | 2024-02-06 | 20.2 |
| 2024-04-10 | 10.2 | 2024-02-05 | 18.7 |
| 2024-04-09 | 10.3 | 2024-02-02 | 19.6 |
| 2024-04-08 | 10.7 | 2024-02-01 | 20.2 |
| 2024-04-05 | 10.0 | 2024-01-31 | 21.4 |
| 2024-04-04 | 10.0 | 2024-01-30 | 21.3 |
| 2024-04-03 | 10.6 | 2024-01-29 | 18.4 |
| 2024-04-02 | 10.8 | 2024-01-26 | 16.6 |
| 2024-04-01 | 10.9 | 2024-01-25 | 16.2 |
| 2024-03-28 | 11.2 | 2024-01-24 | 16.2 |
| 2024-03-27 | 20.1 | 2024-01-23 | 16.4 |
| 2024-03-26 | 19.4 | 2024-01-22 | 15.8 |
| 2024-03-25 | 19.7 | 2024-01-19 | 15.9 |
| 2024-03-22 | 20.8 | 2024-01-18 | 15.6 |
| 2024-03-21 | 20.0 | 2024-01-17 | 15.6 |
| 2024-03-20 | 21.1 | 2024-01-16 | 16.3 |
| 2024-03-19 | 20.2 | 2024-01-12 | 16.7 |
| 2024-03-18 | 20.1 | 2024-01-11 | 16.6 |
Oramed Pharmaceuticals Inc (ORMP) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Oramed Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US68403P2039
Compare
Compare
Traded in other countries / regions
ORMP.USAORMP.IsraelOJU1.Germany IPO Date
2007-05-01Description
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers